Related Experiment Video
Updated: Jun 4, 2025

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
Published on: May 16, 2021
Academic Drug Discovery Units in the UK: Progress and challenges
Michael M Hopkins1, Jorge Mestre-Ferrandiz1, Phillipa Crane1
1Science Policy Research Unit, University of Sussex Business School, University of Sussex, Falmer, Brighton BN1 9SL, UK.
Abstract:
The contributions of academic drug discovery are well characterised in the US context but less well understood elsewhere. This paper provides a UK perspective, focusing on the activities of Drug Discovery Units (DDUs). These units have established themselves as coordinators of translational research, working at the early stages of the drug pipeline to link up the academic and industry capabilities needed to take drug candidates towards the market. Drawing on publicly available sources and interviews with staff from a range of DDUs, the paper reveals DDUs' progress and challenges. While most DDUs have established collaborations with industry, the goal of taking drugs to market remains some way ahead for the vast majority, while sustainable funding is increasingly a concern.
Related Concept Videos
Drug Discovery: Overview
Preclinical Development: Overview
Drug Control Governance: Regulatory Bodies and Their Impact
Clinical Trials: Overview
Drug Regulation
Drug Administration and Therapy Phases: Overview
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...

